Natural history of HBV infection (adapted from Torbenson Lancet 2003) Chronic infection Healthy carriage Recovery occult DNA Anti-HBe Anti-HBc Immune response.

Slides:



Advertisements
Similar presentations
HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.
Advertisements

Treatment appropriate Normal or minimal hepatitis Chronic hepatitis Normal or inactive hepatitis Progressive fibrosis Cirrhosis HCC HBeAg Anti-HBe HBV.
Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013.
HCV-HBV co-infection in Russian Federation Chumakov Institute of Poliomyelitis and Viral Encephalitis, Moscow Karen Kyuregyan VIII Annual Conference of.
Acute Viral Hepatitis. Viral Hepatitis Infectious: Hepatitis A Infectious: Hepatitis A Serum : Hepatitis B, D Serum : Hepatitis B, D NANB : Hepatitis.
F. Kourgia, M. Vini, E. Zervou
HEPATITIS B MARKERS AND VACCINE
OnSite HBsAg /HCV Ab Rapid Test
Screening for HBsAg and Anti-HBc in North American Blood Donors John Saldanha, Roche Molecular Systems SoGAT XXI, May, 2009, Brussels, Belgium.
HIV Testing CDC power point edited by M. Myers
Testing Source Plasma for Hepatitis B Virus by Nucleic Acid Testing Blood Products Advisory Committee Meeting Blood Products Advisory Committee Meeting.
E992750C 1 Replacement of HIV-1 p24 Antigen Screening with HIV-1 RNA Nucleic Acid Testing (NAT) for Whole Blood Donations S.L. Stramer, R.A. Porter, J.P.
Limitations of HBsAg testing in the screening of blood donors Wolfram H. Gerlich Institute of Medical Virology University Giessen, Germany SoGAT XVI Langen.
21 August 2015 Samreen Ijaz Virus Reference Department Health Protection Agency Indigenous HEV infection in the UK: a hazard for blood donation?
Faculty of Allied Medical Sciences Clinical Immunology & Serology Practice (MLIS 201)
BioLife Plasma Services Experience with HBV NAT Testing
Hepatitis B virus Hepatitis viruses: A B formerly serum hepatitis D non A nonB E G.
THE CHANGING FACE OF VIRAL HEPATITIS
Hepatitis B virus Hepatitis viruses: A B formerly serum hepatitis C D non A nonB E G.
Reentry for Donors Deferred Based on Anti-HBc Test Results November 3, 2005 BPAC Meeting FDA/CBER/OBRR/DETTD.
Hepatitis B Virus 28.
Lara Isobel Compston, Daniel Candotti, Jean-Pierre Allain
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
SOGAT Validation of HCV-RNA detection in small test pools on cadaveric samples Marco Koppelman #, Theo Cuypers #, Mirjam de Waal #, Maarten.
Michael Chudy, Paul-Ehrlich-Institut SoGAT XVIII, Bethesda MD
INTRODUCTION High incidence rate High incidence rate Do not grow in the laboratory Do not grow in the laboratory Discovered in 1964 Discovered in 1964.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
HBV genotyping 12/21/07 Carrie Marshall. Received a send-out request for HBV genotyping on a 52y man.
Hepatitis C Virus  Genome resembled that of a flavivirus positive stranded RNA genome of around 10,000 bases  1 single reading frame, structural genes.
Persistent human erythrovirus infection in blood donors National Blood Service, UK Div. Transfusion Medicine, University of Cambridge, UK Public Health.
CHRONIC HEPATITIS B SEROLOGY. Antigens HBsAg -Found on the surface of the intact virus and in serum as unattached particles -Earliest detectable marker.
Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) viremia in women with and at-risk for HIV/AIDS Taylor L, Gholam P, Delong A, Rompalo A, Klein.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Survey of hepatites VirusRelationshipTransmission HAVPicornavirusfaecal-oral HBVSpecial group of DNA viruses sexual, blood HCV (+ HGV)Flavivirusblood HDVDelta.
21th VHPB Meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 Impact of HBV S-gene mutants.
Phylogenetic analysis of genotype 3 parvovirus B19 in Ghana, West Africa.
E001372A 1 ARC Experience with Indeterminate Blood Donors Susan L. Stramer, Ph.D. National Confirmatory Testing Laboratory American Red Cross.
SoGAT June 14, 2006 HCV-RNA and HIV-RNA detection in small test pools of cadaveric samples for viral safety of tissue transplants Maarten Koot#,
Active B19 virions production in hepatoblastoma and hepatocarcinoma cell lines: amplification and genomic stability. Op de beeck A. 1, Draps M.-L. 1, Baurin.
Hepatitis. Hepatitis is an inflammation of the liver. Hepatitis is caused by several types of viruses as well as drug and chemical toxicity.
GI BLOCK; This practical class is designed and Prepared by: Prof. Samy A. Azer (Medical Education) Dr. Ali Somily (Microbiology) Prof. Abdul Mageed.
Management of Donors and Units that Test HBV NAT Positive: Current Considerations July 21, 2005 BPAC Meeting Robin Biswas, M.D. FDA/CBER/OBRR/DETTD.
BBVU Virus Reference Department Centre for Infections
Hepatitis B The Basics David Wong University of Toronto March 2005.
Maternofetal transmission of human parvovirus B19 genotype 3 in Ghana, West Africa D Candotti, K Danso, A Parsyan, A Dompreh, J- P Allain National Blood.
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
Novel and Related Variant Parvoviruses in Human Plasma Jacqueline Fryer and Sally Baylis National Institute for Biological Standards and Control Eric Delwart.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
HBV genotypes E and A deletions and recombination: two sides of the same coin? Penelope Garmiri 1, Andre Loua 2, Daniel Candotti 3 and Jean-Pierre Allain.
Isolated Hepatitis B Core Antibody
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
False negative HBsAg detectionFalse negative HBsAg detection n Is rare in patients with signs of chronic hepatitis B. n May be an issue in low-risk populations,
Hepatitis B Virus Quantitation 진단검사의학과 정유진
Clinicaloptions.com/hepatitis Using Virologic and Serologic Tests in the Management of Hepatitis B Diagnose chronic HBV infection When in slideshow mode,
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
A.Professor Gehan Lotfy abdel Hakeem Minia University Egypt
VIRAL DISEASES OF LIVER DR.JEYAKUMAR NELSON UNIT OF MICROBIOLOGY MBBS -BATCH 17.
In The Name of God.
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
GRIFOLS PLASMA: genotype 2 vB19 sample
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Laboratory Diagnosis of Infectious Diseases
Rapid Molecular Analysis of the STAT3 Gene in Job Syndrome of Hyper-IgE and Recurrent Infectious Diseases  Attila Kumánovics, Carl T. Wittwer, Robert.
Volume 10, Issue 4, Pages (April 1999)
HBV/G Infection of an Apheresis Donor
Viral Safety of Blood Products in Taiwan
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Figure 2 Distribution of markers of active HBV infection
SoGAT meeting XXI May (2009), Brussels, Belgium
Presentation transcript:

Natural history of HBV infection (adapted from Torbenson Lancet 2003) Chronic infection Healthy carriage Recovery occult DNA Anti-HBe Anti-HBc Immune response LowHigh No Serol. marker Viral load Anti-HBs Time 10E3 10E9 Occult chronic infection

Differential diagnosis of occult HBV Marker RecoveredChronic Anti-HBc PositivePositive Anti-HBe + ++ Anti-HBs PositiveNegative Viral load (copies/ml) <10E3 <10E4 PC stop codon No Yes BCP mutations FewFrequent Secondary response Yes No to HBsAg

<10<1E2<1E3<1E4<1E5<1E6<1E7<1E8<1E9 HBV DNA load (IU/ml) Number of samples Distribution of HBV DNA load in 126 HBsAg + and 12 HBsAg - samples from Ghana, West Africa 11% of DNA+ samples are HBsAg -

Investigation of 7 occult HBV infections from Ghanaian blood donors Rapid test HBsAg negative : 5107 EIA neg HBV DNA pos = 12 2d sample negative 4 Studied 7 insufficient volume 1 Presence of virion by Ab capture No signal 1no capture 3Capture + 3 Sequencing

Characterisation of 7 occult HBV ID DNA loadAnti-HBc Anti-HBeAnti-HBs IU/ml Neg Pos Neg Neg Pos Pos Neg Neg Pos Neg Neg Neg Neg

Capture of HBV particles from plasma using magnetic beads Q-PCR Virus in plasma incubated with mouse mAb against ‘a’ determinant overnight + Add magnetic beads with sheep anti-mouse IgG covalently bound Capture on magnetWashLyse captured particle and extract nucleic acid

Preliminary data on occult HBV infection ID Viral anti-HBsAg S seq BCP/PC Complete load capture sequence genome

0.01 substitutions/site HBV whole genome Neighbour-Joining tree A A A A A B B B B B C C D D D E H H H F F F F F G G G G G E E EE C C C D D 100 Sample 245 VL 117 IU/ml Complete sequence of 2 clones

Main sequence features in 4 OBI IDBCP Pre-core Pre-S1/Pre-S2‘a’ SC WT +WT S140L WT + C 2930 del. S140L 1504WT WT T131A 3461WTWT - WT

Substitutions in the ‘a’ loops of HBV genotype E

Anti-HBs response to HBV vaccine of 2 asymptomatic donors with anti-HBc only Days after primary vaccination Anti-HBs (S/CO) Primary injection2d injection

Conclusions Molecular studies of occult HBV are difficult Most include enveloped virions Viral load is consistently <500 IU/ml Detection requires single donation screening Serologically most seem to be anti-HBc only BCP and PC wild type suggest recovered infection despite absence of detectable anti-HBs No evidence of ‘a’ determinant escape was found

E E E E E 1252 H H H F F F F F A A A A A D D DD D B B B B B C C C C C G G G G G substitutions/site Partial S region (490 bp) Neighbour-Joining Tree A D B C G E H F